INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 427m ago
HOUSE PTR26m ago
SEC 13F26m ago
ROBINHOOD CHAIN26m ago
Corporate insider
BC

Brackmann Christoph

Chief Financial OfficerCIK 0002048634

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score39
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Open-market sale
SELL$85K
6,412 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    NovoCure LtdChief Financial Officer · Mar 5, 2026
17
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Grant or award
A
—
55.1K sh
Mar 3, 2026
Mar 5, 2026
traded Mar 3, 2026
+2d
SEC FORM 4

Evidence

9
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Grant or award
A—
80.7K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence